Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia

Current Urology Reports

Volumn 2, Issue 4, 2001, Pages 297-301

  Boon, Tom A ^a   van Venrooij, Ger E P M ^a   Eckhardt, Mardy D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Benign Prostatic Hyperplasia; Bladder Outlet Obstruction; International Prostate Symptom Score; Lower Urinary Tract Symptom; Tamsulosin

Indexed keywords

AGED; DIABETES MELLITUS; HUMAN; MALE; MIDDLE AGED; PROSTATE HYPERTROPHY; REVIEW; URINARY TRACT DISEASE;

AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; UROLOGIC DISEASES;

EID: 0035427937     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-001-0067-z     Document Type: Article

References (13)

1. Starer P, Libow L: Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Arch Intern Med 1990, 150:810–813. DOI: 10.1001/archinte.150.4.810
2. Ueda T, Yoshimura N, Yoshida O: Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 1997, 157:580–584. DOI: 10.1016/S0022-5347(01)65209-1
3. Beck R, Fowler CJ, Mathias CJ: Genitourinary dysfunction in disorders of the autonomic nervous system. In Handbook of Neuro Urology. Edited by Rushton DN. New York: Marcel Dekker; 1994:281–301.
4. Menéndez V, Cofán F, Talbot-Wright R, et al.: Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease. J Urol 1996, 155:2001–2004. DOI: 10.1016/S0022-5347(01)66074-9
5. Michel MC, Mehlburger L, Schumacher H, et al.: Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 2000, 163:1725–1729. DOI: 10.1016/S0022-5347(05)67529-5
6. Barry MJ, Fowler FJ Jr, O’Leary MP, et al.: The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992, 148:1549–1557.
7. Hammarsten J, Högstedt B: Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001, 39:151–158. This is a well-written and interesting article about the role of metabolic disease in the development of BPH. DOI: 10.1159/000052430
8. Recommendations of the International Consensus Committee. In Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Edited by Cockett ATK, Khoury S, Aso Y, et al. Jersey City: Scientific Communication International; 1994:556–564.
9. Roehrborn CG, Kurth KH, Leriche A, et al.: Diagnostic recommendations for clinical practice. In Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Edited by Cockett ATK, Khoury S, Aso Y, et al. Jersey City: Scientific Communication International; 1994:271–342.
10. Schäfer W: Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol 1995, 13:47–58. DOI: 10.1007/BF00182666
11. Lim CS, Abrams P: The Abrams-Griffiths nomogram. World J Urol 1995, 13:34–39. DOI: 10.1007/BF00182664
12. Griffiths D, van Mastrigt R, Bosch R: Quantification of urethral resistance and bladder function during voiding, with special reference to the effects of prostate size reduction on urethral obstruction due to benign prostatic hyperplasia. Neurourol Urodyn 1989, 8:17–27. DOI: 10.1002/nau.1930080104
13. Torffvit O, Agardh CD, Mattiasson A: Lack of association between cystopathy and progression of diabetic nephropathy in insulin-dependent diabetes mellitus. Scand J Urol Nephrol 1997, 31: 365–369.